Stock listing
BX Swiss:COGT Cogent Biosciences, Inc. Aktie
Swiss listing (BX Swiss) of Cogent Biosciences, Inc. · home listing NASDAQ:COGT
Follow Cogent Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:COGT
$31.96 USD -0.27 (-0.8%)
Close on Oct 29, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:COGT
- Day range
- $31.68 – $32.86 USDOct 29, 2026
- Volume
- 1.51M sharesOct 29, 2026
- Market cap
- $5.55B USDAt the close on Oct 29, 2026 · price × 173.5M shares outstanding
- 52-week range
- $13.78 – $43.73 USDLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
- Traded on an average day
- $66.98M USDMedian day 1.81M shares · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:COGT · Home | $31.96 USD | -0.27 (-0.8%) | 1,507,387 | $32.86 | $32.86 | $31.68 | $32.23 | Close on Oct 29, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · NASDAQ:COGT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $31.96 | -0.27 | -0.8% | $32.86 | $32.86 | $31.68 | 1,507,387 | |
| $32.23 | +0.22 | +0.7% | $31.77 | $32.68 | $31.68 | 1,740,882 | |
| $32.01 | +1.10 | +3.6% | $31.10 | $32.22 | $30.72 | 1,838,062 | |
| $30.91 | -0.30 | -1.0% | $31.41 | $31.55 | $30.52 | 2,205,980 | |
| $31.21 | -0.10 | -0.3% | $30.94 | $31.27 | $30.33 | 1,771,236 | |
| $31.31 | -0.12 | -0.4% | $31.07 | $31.91 | $30.86 | 1,178,296 | |
| $31.43 | +0.19 | +0.6% | $31.26 | $31.94 | $31.20 | 2,099,781 | |
| $31.24 | +1.23 | +4.1% | $30.24 | $31.50 | $30.03 | 2,311,787 | |
| $30.01 | +0.49 | +1.7% | $29.66 | $30.23 | $29.51 | 2,541,218 | |
| $29.52 | +0.01 | 0.0% | $29.47 | $29.98 | $28.77 | 2,783,048 | |
| $29.51 | +1.36 | +4.8% | $28.33 | $29.78 | $28.33 | 3,039,765 | |
| $28.15 | +0.06 | +0.2% | $27.93 | $29.05 | $27.74 | 2,295,507 | |
| $28.09 | -1.69 | -5.7% | $29.46 | $29.46 | $27.85 | 2,995,450 | |
| $29.78 | -1.22 | -3.9% | $30.81 | $31.07 | $29.63 | 1,855,295 | |
| $31.00 | +0.92 | +3.1% | $29.98 | $31.03 | $29.90 | 2,522,272 | |
| $30.08 | -0.06 | -0.2% | $29.71 | $30.66 | $28.69 | 3,643,985 | |
| $30.14 | -0.24 | -0.8% | $30.05 | $30.43 | $29.88 | 1,262,894 | |
| $30.38 | -0.49 | -1.6% | $31.17 | $31.17 | $29.70 | 2,383,802 | |
| $30.87 | -0.15 | -0.5% | $31.26 | $31.37 | $29.93 | 1,792,883 | |
| $31.02 | -0.57 | -1.8% | $32.12 | $32.29 | $30.86 | 1,172,134 | |
| $31.59 | -0.43 | -1.3% | $32.02 | $32.57 | $31.52 | 1,698,630 | |
| $32.02 | +0.36 | +1.1% | $31.74 | $32.76 | $31.49 | 1,960,172 | |
| $31.66 | -0.20 | -0.6% | $31.76 | $32.12 | $31.32 | 1,704,731 | |
| $31.86 | -0.45 | -1.4% | $32.00 | $32.20 | $31.23 | 2,212,923 | |
| $32.31 | +0.88 | +2.8% | $31.55 | $32.71 | $31.05 | 2,979,048 | |
| $31.43 | +0.02 | +0.1% | $31.21 | $31.95 | $30.35 | 2,591,471 | |
| $31.41 | -1.22 | -3.7% | $32.62 | $32.85 | $30.88 | 2,330,314 | |
| $32.63 | +0.63 | +2.0% | $32.23 | $32.85 | $32.06 | 2,036,175 | |
| $32.00 | +0.50 | +1.6% | $31.97 | $32.52 | $31.41 | 3,415,438 | |
| $31.50 | -1.69 | -5.1% | $33.21 | $33.42 | $31.39 | 4,604,077 | |
| $33.19 | +0.65 | +2.0% | $33.07 | $33.64 | $32.88 | 1,189,539 | |
| $32.54 | -0.20 | -0.6% | $32.89 | $33.27 | $32.20 | 1,921,689 | |
| $32.74 | -0.67 | -2.0% | $33.37 | $33.93 | $32.69 | 1,712,424 | |
| $33.41 | 0.00 | 0.0% | $33.42 | $33.58 | $32.85 | 1,437,396 | |
| $33.41 | -0.67 | -2.0% | $34.51 | $35.00 | $33.21 | 1,715,802 | |
| $34.08 | -0.10 | -0.3% | $33.50 | $34.19 | $33.07 | 2,264,643 | |
| $34.18 | -1.10 | -3.1% | $35.09 | $35.57 | $34.08 | 1,587,526 | |
| $35.28 | +0.52 | +1.5% | $34.16 | $35.75 | $33.90 | 2,244,424 | |
| $34.76 | -0.19 | -0.5% | $34.56 | $35.20 | $34.42 | 784,080 | |
| $34.95 | +0.38 | +1.1% | $34.90 | $35.14 | $34.06 | 1,268,646 | |
| $34.57 | -0.11 | -0.3% | $35.18 | $35.82 | $34.01 | 1,181,784 | |
| $34.68 | -0.32 | -0.9% | $34.48 | $34.99 | $34.30 | 1,480,641 | |
| $35.00 | +0.33 | +1.0% | $34.61 | $35.21 | $34.11 | 1,849,678 | |
| $34.67 | -2.42 | -6.5% | $36.66 | $36.85 | $34.53 | 1,771,221 | |
| $37.09 | +0.37 | +1.0% | $36.51 | $37.67 | $36.41 | 1,636,565 | |
| $36.72 | -0.08 | -0.2% | $36.49 | $37.12 | $36.28 | 1,062,781 | |
| $36.80 | +0.57 | +1.6% | $36.56 | $37.08 | $36.44 | 1,394,407 | |
| $36.23 | -0.50 | -1.4% | $36.75 | $37.12 | $36.07 | 1,214,545 | |
| $36.73 | +1.42 | +4.0% | $35.75 | $37.22 | $35.40 | 2,515,752 | |
| $35.31 | -1.54 | -4.2% | $36.31 | $36.70 | $34.91 | 1,943,841 | |
| $36.85 | -0.55 | -1.5% | $38.62 | $38.62 | $36.70 | 1,249,799 | |
| $37.40 | -0.47 | -1.2% | $37.32 | $38.31 | $37.01 | 1,151,059 | |
| $37.87 | -0.06 | -0.2% | $37.95 | $38.10 | $37.51 | 1,595,174 | |
| $37.93 | +0.62 | +1.7% | $36.74 | $38.01 | $36.57 | 1,228,832 | |
| $37.31 | -1.67 | -4.3% | $39.06 | $39.30 | $37.30 | 1,414,240 | |
| $38.98 | +0.28 | +0.7% | $38.80 | $39.03 | $37.81 | 2,977,684 | |
| $38.70 | -2.83 | -6.8% | $40.85 | $40.85 | $38.64 | 2,781,611 | |
| $41.53 | -0.86 | -2.0% | $40.44 | $42.00 | $39.72 | 1,616,939 | |
| $42.39 | +0.59 | +1.4% | $42.25 | $42.92 | $41.70 | 1,855,798 | |
| $41.80 | -0.47 | -1.1% | $41.88 | $42.77 | $41.25 | 1,043,363 | |
| $42.27 | -0.57 | -1.3% | $42.75 | $43.30 | $41.46 | 1,881,062 | |
| $42.84 | +3.98 | +10.2% | $39.68 | $43.39 | $39.20 | 4,748,703 | |
| $38.86 | -0.07 | -0.2% | $38.65 | $39.38 | $37.40 | 1,406,506 | |
| $38.93 | -2.43 | -5.9% | $41.13 | $41.31 | $38.76 | 1,547,338 | |
| $41.36 | +1.79 | +4.5% | $39.84 | $42.11 | $39.30 | 1,835,760 | |
| $39.57 | -1.10 | -2.7% | $40.67 | $40.88 | $38.84 | 1,220,992 |
- Ticker
- BX Swiss:COGT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Oct 27, 2026
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 56 slides
Latest news
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Oct 27, 2026
Closed $32.23 (+0.7%) on Oct 28, 2026
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Sep 15, 2026
Closed $32.74 (-2.0%) on Sep 15, 2026
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
Aug 10, 2026
Closed $41.53 (-2.0%) on Aug 10, 2026
Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
Jun 30, 2026
Closed $38.70 (-0.1%) on Jun 30, 2026
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
Jun 12, 2026
Closed $33.10 (+1.5%) on Jun 12, 2026
Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
Jun 12, 2026
Closed $33.10 (+1.5%) on Jun 12, 2026
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2026
Closed $34.81 (-0.4%) on Jun 1, 2026
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST
May 28, 2026
Closed $35.38 (+2.5%) on May 28, 2026
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Closed $34.51 (+1.7%) on May 27, 2026
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
May 12, 2026
Closed $34.53 (+1.3%) on May 12, 2026
Financings
At-the-market programme of shares
Aug 10, 2026
Closed: US$73.6M raised
Use of proceeds: Fund operating expenses and capital expenditures into late 2028, including through potential FDA approvals of bezuclastinib and early commercial launch
Decks
Investor Presentation (September 2026)
Investor deck · 56 slides · September 2026
Technical Presentation (2026)
Technical · 16 slides · 2026
Investor Presentation (December 2025)
Investor deck · 33 slides · Dec 8, 2025
ASH 2025
Conference · 16 slides · December 2025
Cogent Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 149 in all · newest Oct 27, 2026 · oldest 2019
- Decks
- 17 decks · latest September 2026
Where Cogent Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:COGT · Home listing | NASDAQ | United States | USD |
| BX Swiss:COGT · This page | BX Swiss | Switzerland | CHF |
| BOATS:COGT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cogent Biosciences, Inc.